Who founded Eldec Pharmaceuticals?

Eldec Pharmaceuticals was founded by Robert Tarran, Saira Ahmad, Flori Sassano.

Who are Eldec Pharmaceuticals's investors?

Eldec Pharmaceuticals's investors include Cape Fear BioCapital.

How much funding has Eldec Pharmaceuticals raised?

Eldec Pharmaceuticals has disclosed $200K raised across 1 round.

Where is Eldec Pharmaceuticals headquartered?

Eldec Pharmaceuticals is headquartered in Chapel Hill, US.

Eldec Pharmaceuticals

Chapel Hill, US · Delaware corporation · 1 known investors

Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.

Biotech Healthtech

Founders & leadership

Robert TarranCo-founder, President & Chief Scientific Officer

Saira AhmadCo-founder

Flori SassanoCo-founder

Robert SchotzingerExecutive

Robert J. SchotzingerChairman & Chief Executive Officer

Robert HughesChief Financial Officer

Dale J. ChristensenChief Development Officer

Investors · 1

Cape Fear BioCapitalDurham

Reported raises · per SEC filings

Form D private placements

$200K disclosed across 1 round · 2026

▶$200KraisedFeb 2026 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Robert TarranExecutive Officer, Director
Robert SchotzingerExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $200K
First sale: Feb 2026
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Desicorpinc4 shared keywordsDesiCorp develops advanced packaging and stabilization solutions for biopharmaceutical and therapeutic products, extending shelf-life without refrigeration to improve access in rural, remote, and emergency care settings. The company uses specialized materials and two-chambered packaging designs to preserve sensitive compounds during transport and storage in austere environments.

Companies competing with Eldec Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

About - Eldec Pharmaceuticalseldecpharmaceuticals.com · Apr 2025

Our Programs - Eldec Pharmaceuticalseldecpharmaceuticals.com · Sep 2024

About US - Eldec Pharmaceuticalseldecpharmaceuticals.com · Sep 2024

KickStart Venture Services Awards | Innovate Carolina – UNC Innovation & Entrepreneurship | Innovate Carolinainnovate.unc.edu · May 2018

Frequently asked questions

What does Eldec Pharmaceuticals do?: Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.
Who founded Eldec Pharmaceuticals?: Eldec Pharmaceuticals was founded by Robert Tarran, Saira Ahmad, Flori Sassano.
Who are Eldec Pharmaceuticals's investors?: Eldec Pharmaceuticals's investors include Cape Fear BioCapital.
How much funding has Eldec Pharmaceuticals raised?: Eldec Pharmaceuticals has disclosed $200K raised across 1 round.
Where is Eldec Pharmaceuticals headquartered?: Eldec Pharmaceuticals is headquartered in Chapel Hill, US.